Peri- and postoperative morbidity and mortality in elderly patients with non-small cell lung cancer: a matched-pair study

Author:

Safi Seyer1,Gysan Maximilian Robert2,Weber Dorothea3,Behnisch Rouven3,Muley Thomas4,Allgäuer Michael2,Winter Hauke2,Hoffmann Hans1,Eichhorn Martin2

Affiliation:

1. Technical University of Munich

2. Heidelberg University Hospital

3. University of Heidelberg

4. Member of the German Center for Lung Research (DZL)

Abstract

Abstract

Background Reports from case series suggest that operative outcomes are comparable amongst different age groups following surgery with curative intent for non-small cell lung cancer (NSCLC). The purpose of this study was to compare morbidity and mortality after NSCLC surgery in elderly patients (≥ 75 years) versus younger patients (< 75 years) and identify independent predictive risk factors. Methods We identified 2015 patients with postoperative stages IA to IIIA according to AJCC/UICC 7th edition who had undergone NSCLC surgery with curative intent at a single specialized lung cancer center from January 2010 to December 2015. A matched-pair analysis was performed on 227 elderly patients and corresponding 227 younger patients. Short-term surgical outcomes were postoperative morbidity, length of hospital stay, 30-day and 90-day mortality. Long-term operative outcomes were disease-free and overall survival. Results 454 patients were included in the matched-pair analysis. 36% of younger patients developed postoperative complications versus 42% in the elderly (p = 0.163). Age was not significantly associated with the occurrence of postoperative complications. Median length of hospital stay was 14 days in elderly and 13 days in younger patients (p = 0.185). 90-day mortality was 2.2% in younger patients compared to 4% in the elderly (p = 0.424). In the elderly impaired performance status (ECOG ≥ 1) was associated with decreased overall survival (HR = 2.15, CI 1.34–3.46), as were preoperative serum C-reactive protein / albumin ratio ≥ 0.3 (HR = 1.95, CI 1.23–3.11) and elevated preoperative serum creatinine levels ≥ 1.1 mg/dl (HR = 1.84, CI 1.15–2.95). In the younger cohort male sex (HR = 2.26, CI 1.17–4.36), postoperative stage III disease (HR 4.61, CI 2.23–9.54) and preoperative anemia (hemoglobin < 12 g/dl) (HR 2.09, CI 1.10–3.96) were associated with decreased overall survival. Conclusions Preoperative treatment decision-making in the elderly should primarily consider individual assessment of patients’ functional performance and general fitness. Patients should not be excluded from surgery for resectable NSCLC due to advanced age.

Publisher

Springer Science and Business Media LLC

Reference38 articles.

1. Non-small cell lung cancer, version 2.2013;Ettinger DS;J Natl Compr Cancer Network: JNCCN,2013

2. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington JA;Chest,2013

3. Howlader NNA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2013: National Cancer Institute. Bethesda, MD. 2016. https://seer.cancer.gov/archive/csr/1975_2013/. Accessed 12 March 2024.

4. Morbidity and mortality in octogenarians with lung cancer undergoing pneumonectomy;Rodriguez M;Arch Bronconeumol,2015

5. Surgery for lung tumors in the elderly: A retrospective cohort study on the influence of advanced age (over 80 years) on the development of complications by using a multivariate risk model;Stamenovic D;Int J Surg,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3